title: Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration.
abstract: Slit regulates migration of not only neurons, but also nonneuronal cells, such as leukocytes and cancer cells. Slit effect on cancer cell migration has not been well-characterized. In this study, we used several different assays to examine Slit effect on breast cancer cell migration in vitro. We show that ubiquitin-specific protease 33 (USP33)/VDU1, originally identified as a von Hippel-Lindau tumor suppressor (VHL) protein-interacting deubiquitinating enzyme, binds to the Robo1 receptor, and that USP33 is required for Slit responsiveness in breast cancer cells. Slit induces redistribution of Robo1 from intracellular compartments to the plasma membrane in a USP33-dependent manner. Slit impairs directional migration of breast cancer cells without affecting their migration speed. This inhibitory effect is Robo-mediated and USP33-dependent. These data uncover a previously unknown function of USP33 and reveal a new player in Slit-Robo signaling in cancer cell migration.
authors.affiliation: Department of Neurology, Lurie Cancer Center, Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
authors.forename: Junichi
authors.initials: J
authors.lastname: Yuasa-Kawada
authors.forename: Mariko
authors.initials: M
authors.lastname: Kinoshita-Kawada
authors.forename: Yi
authors.initials: Y
authors.lastname: Rao
authors.forename: Jane Y
authors.initials: JY
authors.lastname: Wu
mesh_terms: D015153:Blotting, Western; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D002460:Cell Line; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000235:genetics / Q000502:physiology*; D054377:Chemokine CXCL12 / Q000378:metabolism; D002633:Chemotaxis; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D047468:Immunoprecipitation; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism*; D022101:Microtubule-Organizing Center / Q000378:metabolism; D008870:Microtubules / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000235:genetics; D019718:Receptors, CXCR4 / Q000235:genetics / Q000378:metabolism; D011971:Receptors, Immunologic / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D013314:Stress, Mechanical; D014162:Transfection; D043222:Ubiquitin Thiolesterase / Q000235:genetics / Q000378:metabolism*; D000097905:Roundabout Proteins; D000098552:Slit Homolog 2 Protein
chemical_list: D054377:Chemokine CXCL12; D036341:Intercellular Signaling Peptides and Proteins; D009419:Nerve Tissue Proteins; D034741:RNA, Small Interfering; D019718:Receptors, CXCR4; D011971:Receptors, Immunologic; D043222:Ubiquitin Thiolesterase; D000097905:Roundabout Proteins; D000098552:Slit Homolog 2 Protein; C527276:CXCR4 protein, human; C449799:USP33 protein, human
references.citation: Oncogene. 2006 Aug 24;25(37):5103-12
references.pmid: 16636676
references.citation: Cell. 2001 Oct 19;107(2):209-21
references.pmid: 11672528
references.citation: J Biol Chem. 2002 Feb 15;277(7):4656-62
references.pmid: 11739384
references.citation: Nature. 2003 Aug 14;424(6950):793-6
references.pmid: 12917689
references.citation: Cell. 2005 Dec 2;123(5):773-86
references.pmid: 16325574
references.citation: Nature. 2003 Aug 14;424(6950):797-801
references.pmid: 12917690
references.citation: Cancer Res. 2003 Mar 1;63(5):1054-8
references.pmid: 12615722
references.citation: Nat Rev Cancer. 2004 Dec;4(12):978-87
references.pmid: 15573119
references.citation: J Biol Chem. 2008 Sep 26;283(39):26624-33
references.pmid: 18611862
references.citation: J Cell Biol. 1981 Nov;91(2 Pt 1):589-94
references.pmid: 7309800
references.citation: Trends Cell Biol. 2006 Nov;16(11):551-9
references.pmid: 16996268
references.citation: Nature. 2004 Apr 1;428(6982):1 p  following 486
references.pmid: 15058298
references.citation: J Cell Sci. 1991 Aug;99 ( Pt 4):769-75
references.pmid: 1770004
references.citation: Physiol Rev. 1946 Jul;26(3):319-36
references.pmid: 20993553
references.citation: Cell. 1999 Mar 19;96(6):795-806
references.pmid: 10102268
references.citation: Int J Cancer. 2003 Jan 20;103(3):306-15
references.pmid: 12471613
references.citation: J Clin Invest. 2003 Jul;112(2):189-96
references.pmid: 12865408
references.citation: Curr Opin Genet Dev. 2002 Oct;12(5):583-91
references.pmid: 12200164
references.citation: Annu Rev Cell Dev Biol. 2003;19:141-72
references.pmid: 14570567
references.citation: Nature. 2005 Jul 28;436(7050):518-24
references.pmid: 16049480
references.citation: J Cell Biol. 1999 Nov 1;147(3):577-88
references.pmid: 10545501
references.citation: Cell. 1999 Mar 19;96(6):807-18
references.pmid: 10102269
references.citation: Cell. 1988 Dec 23;55(6):1047-59
references.pmid: 3144436
references.citation: J Biol Chem. 2004 Mar 5;279(10):9115-24
references.pmid: 14645233
references.citation: Nature. 2003 Aug 14;424(6950):801-5
references.pmid: 12917691
references.citation: Cancer Res. 2002 Oct 15;62(20):5874-80
references.pmid: 12384551
references.citation: J Neurosci. 2003 Jun 15;23(12):5170-7
references.pmid: 12832541
references.citation: Nature. 2001 May 24;411(6836):494-8
references.pmid: 11373684
references.citation: Nature. 2001 Apr 19;410(6831):948-52
references.pmid: 11309622
references.citation: Cell. 2001 Aug 24;106(4):489-98
references.pmid: 11525734
references.citation: Oncogene. 2003 Jul 17;22(29):4611-6
references.pmid: 12881718
references.citation: Genes Dev. 2002 Dec 1;16(23):2973-84
references.pmid: 12464628
references.citation: Nat Rev Cancer. 2004 Jul;4(7):540-50
references.pmid: 15229479
references.citation: Biochim Biophys Acta. 2004 Nov 29;1695(1-3):189-207
references.pmid: 15571815
references.citation: Breast Cancer Res Treat. 2007 Dec;106(3):333-42
references.pmid: 17268810
references.citation: Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3257-64
references.pmid: 16740745
references.citation: Cell. 1999 Mar 19;96(6):785-94
references.pmid: 10102267
references.citation: Nat Rev Neurosci. 2003 Dec;4(12):941-56
references.pmid: 14682358
references.citation: Cell. 1998 Jan 23;92(2):205-15
references.pmid: 9458045
references.citation: Methods Mol Biol. 2005;294:31-41
references.pmid: 15576903
references.citation: Science. 2002 Dec 6;298(5600):1959-64
references.pmid: 12471249
references.citation: J Leukoc Biol. 2007 Sep;82(3):465-76
references.pmid: 17565045
references.citation: Dev Biol. 2005 Apr 1;280(1):26-37
references.pmid: 15766745
references.citation: J Cell Biol. 2004 Aug 16;166(4):487-92
references.pmid: 15314065
references.citation: Nature. 1974 May 31;249(456):450-2
references.pmid: 4834231
references.citation: Annu Rev Neurosci. 2003;26:509-63
references.pmid: 12677003
references.citation: Biochem Biophys Res Commun. 2002 Jun 14;294(3):700-9
references.pmid: 12056827
references.citation: Nature. 1999 Jul 22;400(6742):331-6
references.pmid: 10432110
references.citation: Br J Cancer. 2004 Dec 13;91(12):2071-8
references.pmid: 15534609
references.citation: Nature. 2002 Apr 11;416(6881):648-53
references.pmid: 11923872
references.citation: Nature. 2001 Mar 1;410(6824):50-6
references.pmid: 11242036
references.citation: Nat Rev Cancer. 2008 Aug;8(8):618-31
references.pmid: 18633355
references.citation: EMBO Rep. 2005 Apr;6(4):373-8
references.pmid: 15776016
references.citation: Annu Rev Biochem. 1998;67:425-79
references.pmid: 9759494
references.citation: Oncogene. 1998 Oct 1;17(13):1723-9
references.pmid: 9796701
references.citation: Nature. 2005 Jul 14;436(7048):193-200
references.pmid: 16015319